Mrna-Based Vaccines Suppliers & Bulk Manufacturers

Available Forms: Injectable suspension

Available Strengths: 30 µg and 100 µg

Reference Brands: Comirnaty, Spikevax(US)

Category: Vaccines

mRNA-based Vaccines is available in Injectable suspension and strengths such as 30 µg and 100 µg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, mRNA-based Vaccines is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

mRNA-based Vaccines can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: mRNA-based vaccines, such as Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves rigorous clinical trials, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing processes. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees safe, effective COVID-19 protection globally, supporting public health efforts.